A phase II study with gemcitabine and split-dose cisplatin in patients with advanced non-small cell lung cancer-Reference-Cited by-同舟云学术

A phase II study with gemcitabine and split-dose cisplatin in patients with advanced non-small cell lung cancer

Published:2006-10 Issue:1 Volume:54 Page:57-62
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Kim Jung Han,Lee Dong Hun,Shin Hyun Chun,Kwon Jung Hye,Jung Joo Young,Kim Hyo Jung,Song Hun Ho,Lee Keun Seok,Zang Dae Young,Ahn Jin Seok,Park Young Lee,Lee Jung-Ae

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference22 articles.

1. Chemotherapy for non-small cell lung cancer. Part 1: Early stage disease;Novello;Oncology,2003

2. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised trials;Non-small Cell Lung Cancer Collaborative Group;Br Med J,1995

3. Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group;Gridelli;J Clin Oncol,2003

4. Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial;Georgoulias;Lancet,2001

5. Efficacy study of intensive cisplatin therapy in advanced non-small cell bronchogenic carcinoma;Vogl;Cancer,1982

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial of olanzapine plus triple antiemetic regimen for the prevention of multiday highly emetogenic chemotherapy-induced nausea and vomiting (OFFER study);eClinicalMedicine;2023-01

2. A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancer;Therapeutic Advances in Medical Oncology;2021-01

3. A randomized phase II trial of cisplatin plus gemcitabine versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT0703);Cancer Chemotherapy and Pharmacology;2020-06-20

4. Cisplatin given at three divided doses for three consecutive days in metastatic breast cancer: an alternative schedule for one full dose with comparable efficacy but less CINV and hypomagnesaemia;Breast Cancer Research and Treatment;2020-06-10

5. Effect of pemetrexed on brain metastases from nonsmall cell lung cancer with wild-type and unknown EGFR status;Medicine;2019-01